Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 2:17 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 841–864 of 2,718 matching trials from the live ClinicalTrials.gov search.

Filters: Sponsor: Duke University Clear all

Conditions: Pain, Postoperative
Interventions: methadone hydrochloride 0.1mg/kg; Drug
Lead sponsor: Kanecia Obie Zimmerman; Other
Eligibility: 18 Years to 40 Years
Enrollment: 22 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Hand Foot Syndrome, Palmar Plantar Erythrodysesthesia
Interventions: sildenafil citrate; Drug
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 90 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Endometrial Diseases, Pain, Postoperative
Interventions: TENS 7000; Device
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 149 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Colorectal Cancer
Interventions: mHealth Coping Skills Training for Symptom Management (mCOPE); Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 50 Years
Enrollment: 167 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 2
States / cities: Durham, North Carolina

Conditions: Malignant Neoplasms of Brain
Interventions: PEP-3 vaccine, sargramostim, Temozolomide; Biological · Drug
Lead sponsor: John Sampson; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2016
U.S. locations: 2
States / cities: Durham, North Carolina • Houston, Texas

Conditions: Invasive Candidiasis
Interventions: Not listed
Lead sponsor: Duke University; Other
Eligibility: 120 Days to 18 Years
Enrollment: 515 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 19
States / cities: Little Rock, Arkansas • Orange, California • San Diego, California + 16 more

Conditions: Talaromycosis
Interventions: Liposomal Amphotericin B (LAmB), Flucytosine (5FC), Flucytosine (5FC) placebo pill, Deoxycholate Amphotericin B (DAmB); Drug
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 428 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Cardiac Rehabilitation, Heart Disease
Interventions: Not listed
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Brain Injuries, Traumatic
Interventions: brain pulse oximeter; Device
Lead sponsor: Cyban Pty Ltd; Industry
Eligibility: 18 Years to 45 Years
Enrollment: 21 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Morbid Obesity
Interventions: Not listed
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Pharmacogenetics, Medication Therapy Management
Interventions: MTM with PGx; Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Anorexia Nervosa
Interventions: One hour supervised exercise session; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Adolescent Idiopathic Scoliosis
Interventions: Not listed
Lead sponsor: Duke University; Other
Eligibility: 12 Years to 18 Years · Female only
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Osteoporosis
Interventions: Donepezil, Memantine; Drug
Lead sponsor: Duke University; Other
Eligibility: 50 Years and older
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Pancreatic Cancer, Surgery
Interventions: Not listed
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Pulmonary Hypertension
Interventions: Iloprost and nitric oxide administration; Drug
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Childhood Depression, Childhood Anxiety, Pediatric Pain, Migraines, ADHD, Pediatric Stomach Pain, Musculoskeletal Pain
Interventions: Integrative Coping Group; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 10 Years to 12 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Seizures, Epilepsy, Seizure Disorder
Interventions: ANT recording and stimulation; Procedure
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Renal Cell Carcinoma
Interventions: chart abstraction, Educational Program; Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Fatigue
Interventions: Survey; Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Malignant Glioma of Brain
Interventions: Irinotecan, Panitumumab; Drug
Lead sponsor: Annick Desjardins; Other
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Leukemia
Interventions: Gemcitabine Hydrochloride, Mitoxantrone Hydrochloride; Drug
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2011
U.S. locations: 2
States / cities: Durham, North Carolina • Cleveland, Ohio

Conditions: Pain, Postoperative
Interventions: Lavender Essential Oil; Drug
Lead sponsor: Scott Hollenbeck, MD; Other
Eligibility: 18 Years to 85 Years · Female only
Enrollment: 58 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Prostate Cancer
Interventions: pembrolizumab, Low dose prostate radiation, Radical Prostatectomy; Drug · Radiation · Procedure
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older · Male only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Durham, North Carolina

Search by objective public record fields.

Single Dose IV Methadone for Post-Op Pain

Treatment of Palmar Plantar Erythrodysesthesia (PPE) With Topical Sildenafil

Transcutaneous Electrical Nerve Stimulation During Outpatient Endometrial Biopsy

An mHealth Symptom Management Intervention for Colorectal Cancer Patients (mCOPE)

Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

BIOPIC: Fungal Biomarkers for Diagnosis and Response to Therapy for Pediatric Candidemia

Liposomal Amphotericin B and Flucytosine Antifungal Strategy for Talaromycosis (LAmB-FAST)

Sex Differences in Barriers and Participation in Physical Activity During and Following Cardiac Rehabilitation

Brain Oximeter Calibration and Validation Study

Prospective Case-Series of Ligasure Advance Pistol Grip and LigaSure Blunt Tip

Medication Therapy Management With Pharmacogenetic Testing

Heart Rate Sensing and Response in Persons With Anorexia Nervosa

Function and Scoliosis Surgery

Effect of Acetylcholinesterase Inhibitors on Bone Metabolism

Immunologic Signatures Following Surgery for Pancreatic Cancer

Outpatient Vasodilator Assessment Using Iloprost in Pulmonary Hypertension

Integrative Coping Group for Children

Thalamic Stimulation for Epilepsy Study

NCCN Renal Cell Registry

Measuring Fatigue in Triage: A Pilot Study

Panitumumab and Irinotecan for Malignant Gliomas

Gemcitabine and Mitoxantrone in Treating Patients With Relapsed Acute Myeloid Leukemia

Effects of Lavender Oil on Postoperative Pain, Sleep Quality and Mood

Trimodality Approach of Low Dose iOnizing Radiation With or Without Neoadjuvant Pembrolizumab and Prostatectomy for Men With Intermediate/High Risk Prostate Cancer (TALON)